SCHEMBL7089567

SCHEMBL7089567

c1cc2ccc(-n3ccc4ccccc43)oc-2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC5 O15392 1/20 0.40
PRKD3 O94806 1/20 0.39
PRKCG P05129 1/20 0.39
PRKCB P05771 1/20 0.39
PRKCA P17252 1/20 0.39
PRKACA P17612 1/20 0.39
PRKACG P22612 1/20 0.39
PRKACB P22694 1/20 0.39
PRKCH P24723 1/20 0.39
PRKCI P41743 1/20 0.39
PRKCE Q02156 1/20 0.39
PRKCQ Q04759 1/20 0.39
PRKCZ Q05513 1/20 0.39
PRKCD Q05655 1/20 0.39
PRKD1 Q15139 1/20 0.39
MAOB P27338 4/20 0.38
MAOA P21397 2/20 0.38
CDC7 O00311 1/20 0.36
CDK2 P24941 1/20 0.36
ROCK1 Q13464 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4740418 0.69 KDM4E (0.38) ALDH1A1MAPTNPC1RAB9A
SCHEMBL5792785 0.68 BIRC5 (0.67) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL927134 0.68 MAOB (0.52) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL13242029 0.67 BIRC5 (0.71) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL11229668 0.67 BIRC5 (0.46) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL31087256 0.65 CDC7 (0.42) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL24886410 0.65 BIRC5 (0.51) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL10112723 0.65 BIRC5 (0.51) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL2758570 0.65 BIRC5 (0.61) BIRC5PRKD3PRKCGPRKCBPRKCA
SCHEMBL11910172 0.64 BIRC5 (0.60) BIRC5PRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 BIRC5 3817/4885PRKD3 3305/4885PRKCG 4484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.